Regarding lack of access to the Bridge Program, we want to clarify the following: Under federal law, Medicare Part D plans cannot cover medications prescribed for weight loss Medications that are FDA-approved for both weight loss and other indications may only be covered by Part D plans for non-weight loss indications. This Bridge Program is a trial of a way to address the particular problem of Part D restrictions on weight-loss prescriptions
These combined effects help lower blood glucose levels and may contribute to weight loss
It supports real recovery
Update 26 (2), 247263
Controlled release of liraglutide using thermogelling polymers in treatment of diabetes
Obesity, a complex metabolic disorder, is associated with numerous comorbidities, including cardiovascular diseases, type 2 diabetes, and various ocular complications 3,4,5,6,7,8